QA: Forty Seven Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001667633_2020_Forty_Seven_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001667633, Forty Seven Inc

  xvar xval
0 AssetsCurrent 337,524,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,223,000
3 remainder_Assets 4,846,000
4 LiabilitiesCurrent 22,795,000
5 LiabilitiesNoncurrent 844,000
6 remainder_Liabilities 2,026,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,418,000
9 ResearchAndDevelopmentExpense 83,792,000
10 remainder_Expenses 2,554,000
11 remainder_Revenues 19,143,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 174,000
  yvar yval
0 Assets 343,593,000
1 Liabilities 25,665,000
2 Expenses 106,764,000
3 Revenues 19,143,000
4 StockholdersEquity 317,928,000
5 NetIncome -87,621,000
6 ComprehensiveNetIncome -87,534,000
7 BaseVar 247,669,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.28
9 EconomicCapitalRatio 3.88

Edgar->Model Mapping

Feature Distribution